Sorry, you need to enable JavaScript to visit this website.
Skip to main content
Study

Toward safer opioid prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial.

Cedillo G, George MC, Deshpande R, et al. Toward safer opioid prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial. Addict Sci Clin Pract. 2022;17(1):28. doi:10.1186/s13722-022-00311-8.

Save
Print
June 22, 2022
Cedillo G, George MC, Deshpande R, et al. Addict Sci Clin Pract. 2022;17(1):28.
View more articles from the same authors.

In 2016, the Centers for Disease Control (CDC) issued an opioid prescribing guideline intended to reverse the increasing death rate from opioid overdoses. This study describes the development, implementation, and effect of a safe prescribing strategy (TOWER) in an HIV-focused primary care setting. Providers using TOWER were more adherent to the CDC guidelines, with no worsening patient-reported outcome measures.

Save
Print
Cite
Citation

Cedillo G, George MC, Deshpande R, et al. Toward safer opioid prescribing in HIV care (TOWER): a mixed-methods, cluster-randomized trial. Addict Sci Clin Pract. 2022;17(1):28. doi:10.1186/s13722-022-00311-8.

Related Resources From the Same Author(s)